Last reviewed · How we verify

NCT05804461

Optimizing Pre-Exposure Prophylaxis (PrEP) Among Latino Men Who Have Sex With Men (MSM) in Puerto Rico

Recruiting now NA Last updated 30 May 2025
What this trial tests

NA trial testing Motivational Interviewing in HIV Prevention in 182 participants. Currently enrolling.

Timeline
1 September 2023
Primary endpoint
31 May 2026
31 May 2026

Quick facts

Lead sponsorUniversity of Puerto Rico
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment182
Start date1 September 2023
Primary completion31 May 2026
Estimated completion31 May 2026
Sites1 location across Puerto Rico

Drugs / interventions tested

Conditions studied

Sponsor

University of Puerto Rico

Who can join

Adults 21 to 99, male only, with HIV Prevention. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To develop, assess and compare the effectiveness of a Motivational Interviewing Intervention for increasing Pre-Exposure Prophylaxis (PrEP) uptake among Latino Men Who Have Sex With Men (MSM) in Puerto Rico.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Motivational Interviewing

Trials testing the same drug.

Other recruiting trials for HIV Prevention

Currently open trials in the same condition.

Other University of Puerto Rico trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05804461.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing